Guidance

Reporting adverse incidents involving software as a medical device under the vigilance system

Information for manufacturers of software as a medical device, detailing events that may cause indirect harm and are therefore reportable.

Documents

Details

This document provides guidance for manufacturers of software as a medical device. It outlines events that may cause indirect harm and are therefore reportable. Read it in conjunction with the guidance on post market surveillance which sets out the general adverse incident reporting obligations on all manufacturers of medical devices including software as a medical device. 

»Ê¹ÚÌåÓýapp aim of this guidance is to complement the requirements of . You should read it in conjunction with this regulation. Device-specific guidance does not replace or extend these requirements.

Updates to this page

Published 15 May 2023
Last updated 15 January 2025 show all updates
  1. Updated to reflect the laying of »Ê¹ÚÌåÓýapp Medical Devices (Post-market Surveillance requirements) (Amendment) Regulations 2024.

  2. First published.

Sign up for emails or print this page